Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68378050%3A_____%2F16%3A00483285" target="_blank" >RIV/68378050:_____/16:00483285 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1111/sji.12436" target="_blank" >http://dx.doi.org/10.1111/sji.12436</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/sji.12436" target="_blank" >10.1111/sji.12436</a>

Result language
angličtina
Original language name
Identification of Biological and Pharmaceutical Mast Cell- and Basophil-Related Targets
Original language description
In this letter to editor, 20 students and eight trainers from 11 countries all across Europe met at the two-day training school action held in Uppsala, Sweden. In the frame of the COST Action BM1007 “Mast cells and basophils - Target for Innovative Therapies they discussed various aspects of mast cells physiology. The topics summarized in the letter involved (1) mast cell and basophil development in vivo and in vitro (2) mast cell- and basophil-deficient mouse, (3) the difference between human and mouse mast cells and basophil, and (4) are tyrosine kinase inhibitors potential targets for mast cell- and basophil-driven diseases? The combined data show accumulated knowledge about mast cell and basophils physiology and suggest new possibilities to treat mast cell- and basophil-mediated diseases.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30102 - Immunology

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)